Skip to content
    The Baupost Group logo

    The Baupost Group

    Boston, Massachusetts, United StatesFounded 1982

    The Baupost Group is a Boston-based investment manager with a long-term, value-oriented, multi-strategy approach. Founded in 1982, it invests across publicly traded debt and equity securities, private credit, private equity, and real estate on behalf of families, foundations, and endowments.

    32% of their portfolio is in Healthcare. Average disclosed round size is $360.7M (across 20 rounds with reported amounts).

    Find people at The Baupost Group on Goldilocks AI

    Portfolio

    17

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    0

    Team

    JL

    JJ Lenhart

    Managing Director

    NC

    Nathaniel Casey

    Managing Director

    JP

    Jason Price

    Partner

    EU

    Eric Utay

    Principal

    NG

    Nick Gupta

    Principal, Public Investments

    DR

    Daniel Romeu

    Investment Analyst

    MM

    Michael Mao

    Investment Analyst

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    22 investments
    CompanyRoundAmountDate
    DayOne logoDayOneSeries B$1.9BJan 2025
    RRail Modal GroupSeries C$50MJan 2023
    Ro logoRoGrowth$150MFeb 2022
    Ro logoRoSeries A$150MFeb 2022
    Ro logoRoSeries C$150MJan 2022
    Outbrain logoOutbrainGrowth$200MJul 2021
    Cellarity logoCellaritySeries B$123MFeb 2021
    Arrive logoArriveSeed$300MJan 2021
    Arrive Logistics logoArrive LogisticsSeries D$300MJan 2021
    AUTO1 Group logoAUTO1 GroupUnknown—Jan 2020
    Joby Aviation logoJoby AviationSeries C$590MJan 2020
    Nuvation Bio logoNuvation BioUnknown$275MOct 2019
    Nuvation Bio logoNuvation BioSeries A$275MJan 2019
    GGossamerSeries B$230MJul 2018
    Translate Bio logoTranslate BioSeries B$55MJan 2017
    Intarcia logoIntarciaUnknown$215MSep 2016
    Translate Bio logoTranslate BioSeries C$51MJan 2016
    AAtaraSeries B$38.5MDec 2013
    Intarcia logoIntarciaSeries A$210MNov 2012
    FFinch Therapeutics GroupGrowth——
    Atara Bio logoAtara BioSeries B$52M—
    DayOne logoDayOneSeries A$1.9B—

    Top Co-Investors

    Last updated: 7 October 2026